Please Wait.....
Report
In Vitro Diagnostics Market (Product & Service: Reagents & Kits, Instruments, and Software & Services; and Technology: Immunoassay, Clinical Chemistry, Molecular Diagnostics, Blood Glucose Monitoring, Hematology, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
Market Report I 2024-03-20 I 237 Pages I Transparency Market Research
In Vitro Diagnostics Market - Scope of Report
TMR's report on the global in vitro diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global in vitro diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in vitro diagnostics market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in vitro diagnostics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vitro diagnostics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in vitro diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in vitro diagnostics market.
The report delves into the competitive landscape of the global in vitro diagnostics market. Key players operating in the global in vitro diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in vitro diagnostics market profiled in this report.
Key Questions Answered in Global in vitro diagnostics Market Report
- What is the sales/revenue generated by in vitro diagnostics across all regions during the forecast period?
- What are the opportunities in the global in vitro diagnostics market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
In Vitro Diagnostics Market - Research Objectives and Research Approach
The comprehensive report on the global in vitro diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global in vitro diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vitro diagnostics market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global In Vitro Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global In Vitro Diagnostics Market Analysis and Forecasts, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario
5.3. Price Analysis
5.4. Top Player Positioning
5.5. Covid-19 Pandemic Impact on Industry
6. Global In Vitro Diagnostics Market Analysis and Forecasts, By Product & Service
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product & Service, 2017-2031
6.3.1. Reagents & Kits
6.3.2. Instruments
6.3.3. Software & Services
6.4. Market Attractiveness By Product & Service
7. Global In Vitro Diagnostics Market Analysis and Forecasts, By Technology
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Technology, 2017-2031
7.3.1. Clinical Chemistry
7.3.1.1. Metabolic Panel
7.3.1.2. Electrolyte Panel
7.3.1.3. Liver Panel
7.3.1.4. Lipid Profile
7.3.1.5. Renal Profile
7.3.1.6. Thyroid Function Panel
7.3.2. Immunoassay
7.3.2.1. ELISA
7.3.2.2. ELISPOT
7.3.2.3. Rapid Test
7.3.2.4. Others
7.3.3. Molecular Diagnostics
7.3.3.1. PCR
7.3.3.2. Isothermal Nucleic Acid Amplification Technology
7.3.3.3. Microarray
7.3.3.4. Hybridization
7.3.3.5. DNA Sequencing & Next-Generation Sequencing
7.3.4. Blood Glucose Monitoring
7.3.5. Hematology
7.3.6. Others (Mass Spectrometry, etc.)
7.4. Market Attractiveness By Technology
8. Global In Vitro Diagnostics Market Analysis and Forecasts, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Application, 2017-2031
8.3.1. Oncology
8.3.2. Infectious Diseases
8.3.3. Metabolic Diseases
8.3.4. Cardiology
8.3.5. Nephrology
8.3.6. Drug Testing/pharmacogenomics
8.3.7. Autoimmune Diseases
8.3.8. Others
8.4. Market Attractiveness By Application
9. Global In Vitro Diagnostics Market Analysis and Forecasts, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2017-2031
9.3.1. Diagnostic Centers
9.3.2. Hospital-based Laboratories
9.3.3. Academic & Research Institutes
9.3.4. Home care
9.3.5. Others
9.4. Market Attractiveness By End-user
10. Global In Vitro Diagnostics Market Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America In Vitro Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product & Service, 2017-2031
11.2.1. Reagents & Kits
11.2.2. Instruments
11.2.3. Software & Services
11.3. Market Value Forecast By Technology, 2017-2031
11.3.1. Clinical Chemistry
11.3.1.1. Metabolic Panel
11.3.1.2. Electrolyte Panel
11.3.1.3. Liver Panel
11.3.1.4. Lipid Profile
11.3.1.5. Renal Profile
11.3.1.6. Thyroid Function Panel
11.3.2. Immunoassay
11.3.2.1. ELISA
11.3.2.2. ELISPOT
11.3.2.3. Rapid Test
11.3.2.4. Others
11.3.3. Molecular Diagnostics
11.3.3.1. PCR
11.3.3.2. Isothermal Nucleic Acid Amplification Technology
11.3.3.3. Microarray
11.3.3.4. Hybridization
11.3.3.5. DNA Sequencing & Next-Generation Sequencing
11.3.4. Blood Glucose Monitoring
11.3.5. Hematology
11.3.6. Others (Mass Spectrometry, etc.)
11.4. Market Value Forecast By Application, 2017-2031
11.4.1. Oncology
11.4.2. Infectious Diseases
11.4.3. Metabolic Diseases
11.4.4. Cardiology
11.4.5. Nephrology
11.4.6. Drug Testing/pharmacogenomics
11.4.7. Autoimmune Diseases
11.4.8. Others
11.5. Market Value Forecast By End-user, 2017-2031
11.5.1. Diagnostic Centers
11.5.2. Hospital-based Laboratories
11.5.3. Academic & Research Institutes
11.5.4. Home care
11.5.5. Others
11.6. Market Value Forecast By Country/Sub-region, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product & Service
11.7.2. By Technology
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe In Vitro Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product & Service, 2017-2031
12.2.1. Reagents & Kits
12.2.2. Instruments
12.2.3. Software & Services
12.3. Market Value Forecast By Technology, 2017-2031
12.3.1. Clinical Chemistry
12.3.1.1. Metabolic Panel
12.3.1.2. Electrolyte Panel
12.3.1.3. Liver Panel
12.3.1.4. Lipid Profile
12.3.1.5. Renal Profile
12.3.1.6. Thyroid Function Panel
12.3.2. Immunoassay
12.3.2.1. ELISA
12.3.2.2. ELISPOT
12.3.2.3. Rapid Test
12.3.2.4. Others
12.3.3. Molecular Diagnostics
12.3.3.1. PCR
12.3.3.2. Isothermal Nucleic Acid Amplification Technology
12.3.3.3. Microarray
12.3.3.4. Hybridization
12.3.3.5. DNA Sequencing & Next-Generation Sequencing
12.3.4. Blood Glucose Monitoring
12.3.5. Hematology
12.3.6. Others (Mass Spectrometry, etc.)
12.4. Market Value Forecast By Application, 2017-2031
12.4.1. Oncology
12.4.2. Infectious Diseases
12.4.3. Metabolic Diseases
12.4.4. Cardiology
12.4.5. Nephrology
12.4.6. Drug Testing/pharmacogenomics
12.4.7. Autoimmune Diseases
12.4.8. Others
12.5. Market Value Forecast By End-user, 2017-2031
12.5.1. Diagnostic Centers
12.5.2. Hospital-based Laboratories
12.5.3. Academic & Research Institutes
12.5.4. Home care
12.5.5. Others
12.6. Market Value Forecast By Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product & Service
12.7.2. By Technology
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific In Vitro Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product & Service, 2017-2031
13.2.1. Reagents & Kits
13.2.2. Instruments
13.2.3. Software & Services
13.3. Market Value Forecast By Technology, 2017-2031
13.3.1. Clinical Chemistry
13.3.1.1. Metabolic Panel
13.3.1.2. Electrolyte Panel
13.3.1.3. Liver Panel
13.3.1.4. Lipid Profile
13.3.1.5. Renal Profile
13.3.1.6. Thyroid Function Panel
13.3.2. Immunoassay
13.3.2.1. ELISA
13.3.2.2. ELISPOT
13.3.2.3. Rapid Test
13.3.2.4. Others
13.3.3. Molecular Diagnostics
13.3.3.1. PCR
13.3.3.2. Isothermal Nucleic Acid Amplification Technology
13.3.3.3. Microarray
13.3.3.4. Hybridization
13.3.3.5. DNA Sequencing & Next-Generation Sequencing
13.3.4. Blood Glucose Monitoring
13.3.5. Hematology
13.3.6. Others (Mass Spectrometry, etc.)
13.4. Market Value Forecast By Application, 2017-2031
13.4.1. Oncology
13.4.2. Infectious Diseases
13.4.3. Metabolic Diseases
13.4.4. Cardiology
13.4.5. Nephrology
13.4.6. Drug Testing/pharmacogenomics
13.4.7. Autoimmune Diseases
13.4.8. Others
13.5. Market Value Forecast By End-user, 2017-2031
13.5.1. Diagnostic Centers
13.5.2. Hospital-based Laboratories
13.5.3. Academic & Research Institutes
13.5.4. Home care
13.5.5. Others
13.6. Market Value Forecast By Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product & Service
13.7.2. By Technology
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America In Vitro Diagnostics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Product & Service, 2017-2031
14.2.1. Reagents & Kits
14.2.2. Instruments
14.2.3. Software & Services
14.3. Market Value Forecast By Technology, 2017-2031
14.3.1. Clinical Chemistry
14.3.1.1. Metabolic Panel
14.3.1.2. Electrolyte Panel
14.3.1.3. Liver Panel
14.3.1.4. Lipid Profile
14.3.1.5. Renal Profile
14.3.1.6. Thyroid Function Panel
14.3.2. Immunoassay
14.3.2.1. ELISA
14.3.2.2. ELISPOT
14.3.2.3. Rapid Test
14.3.2.4. Others
14.3.3. Molecular Diagnostics
14.3.3.1. PCR
14.3.3.2. Isothermal Nucleic Acid Amplification Technology
14.3.3.3. Microarray
14.3.3.4. Hybridization
14.3.3.5. DNA Sequencing & Next-Generation Sequencing
14.3.4. Blood Glucose Monitoring
14.3.5. Hematology
14.3.6. Others (Mass Spectrometry, etc.)
14.4. Market Value Forecast By Application, 2017-2031
14.4.1. Oncology
14.4.2. Infectious Diseases
14.4.3. Metabolic Diseases
14.4.4. Cardiology
14.4.5. Nephrology
14.4.6. Drug Testing/pharmacogenomics
14.4.7. Autoimmune Diseases
14.4.8. Others
14.5. Market Value Forecast By End-user, 2017-2031
14.5.1. Diagnostic Centers
14.5.2. Hospital-based Laboratories
14.5.3. Academic & Research Institutes
14.5.4. Home care
14.5.5. Others
14.6. Market Value Forecast By Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product & Service
14.7.2. By Technology
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa In Vitro Diagnostics Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Product & Service, 2017-2031
15.2.1. Reagents & Kits
15.2.2. Instruments
15.2.3. Software & Services
15.3. Market Value Forecast By Technology, 2017-2031
15.3.1. Clinical Chemistry
15.3.1.1. Metabolic Panel
15.3.1.2. Electrolyte Panel
15.3.1.3. Liver Panel
15.3.1.4. Lipid Profile
15.3.1.5. Renal Profile
15.3.1.6. Thyroid Function Panel
15.3.2. Immunoassay
15.3.2.1. ELISA
15.3.2.2. ELISPOT
15.3.2.3. Rapid Test
15.3.2.4. Others
15.3.3. Molecular Diagnostics
15.3.3.1. PCR
15.3.3.2. Isothermal Nucleic Acid Amplification Technology
15.3.3.3. Microarray
15.3.3.4. Hybridization
15.3.3.5. DNA Sequencing & Next-Generation Sequencing
15.3.4. Blood Glucose Monitoring
15.3.5. Hematology
15.3.6. Others (Mass Spectrometry, etc.)
15.4. Market Value Forecast By Application, 2017-2031
15.4.1. Oncology
15.4.2. Infectious Diseases
15.4.3. Metabolic Diseases
15.4.4. Cardiology
15.4.5. Nephrology
15.4.6. Drug Testing/pharmacogenomics
15.4.7. Autoimmune Diseases
15.4.8. Others
15.5. Market Value Forecast By End-user, 2017-2031
15.5.1. Diagnostic Centers
15.5.2. Hospital-based Laboratories
15.5.3. Academic & Research Institutes
15.5.4. Home care
15.5.5. Others
15.6. Market Value Forecast By Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product & Service
15.7.2. By Technology
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles
16.2.1. Danaher Corporation
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. Financial Overview
16.2.1.4. SWOT Analysis
16.2.1.5. Strategic Overview
16.2.2. F. Hoffmann-La Roche Ltd.
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. Financial Overview
16.2.2.4. SWOT Analysis
16.2.2.5. Strategic Overview
16.2.3. Thermo Fisher Scientific Inc.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. Financial Overview
16.2.3.4. SWOT Analysis
16.2.3.5. Strategic Overview
16.2.4. Becton, Dickinson, and Company
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. Financial Overview
16.2.4.4. SWOT Analysis
16.2.4.5. Strategic Overview
16.2.5. QIAGEN N.V.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. Financial Overview
16.2.5.4. SWOT Analysis
16.2.5.5. Strategic Overview
16.2.6. bioMerieux SA
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. Financial Overview
16.2.6.4. SWOT Analysis
16.2.6.5. Strategic Overview
16.2.7. Siemens Healthcare GmbH
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. Financial Overview
16.2.7.4. SWOT Analysis
16.2.7.5. Strategic Overview
16.2.8. Abbott Laboratories
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. Financial Overview
16.2.8.4. SWOT Analysis
16.2.8.5. Strategic Overview
16.2.9. Agilent Technologies, Inc.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. Financial Overview
16.2.9.4. SWOT Analysis
16.2.9.5. Strategic Overview
16.2.10. Bio-Rad Laboratories, Inc.
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. Financial Overview
16.2.10.4. SWOT Analysis
16.2.10.5. Strategic Overview
16.2.11. Chembio Diagnostics, Inc.
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Product Portfolio
16.2.11.3. Financial Overview
16.2.11.4. SWOT Analysis
16.2.11.5. Strategic Overview
16.2.12. Sysmex Corporation
16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.12.2. Product Portfolio
16.2.12.3. Financial Overview
16.2.12.4. SWOT Analysis
16.2.12.5. Strategic Overview
16.2.13. QuidelOrtho Corporation.
16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.13.2. Product Portfolio
16.2.13.3. Financial Overview
16.2.13.4. SWOT Analysis
16.2.13.5. Strategic Overview
16.2.14. Illumina, Inc.
16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.14.2. Product Portfolio
16.2.14.3. Financial Overview
16.2.14.4. SWOT Analysis
16.2.14.5. Strategic Overview
List of Tables
Table 01: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 02: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 03: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 08: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 09: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 10: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 11: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 12: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 13: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 14: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 15: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 16: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 17: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 18: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 19: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 20: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 21: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 22: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 23: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 24: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 25: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 26: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 27: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 28: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 29: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 30: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 31: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 32: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 33: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 34: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 35: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 36: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 37: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 38: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 39: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Product & Service, 2017-2031
Table 40: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2031
Table 41: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Immunoassay, 2017-2031
Table 42: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Clinical Chemistry, 2017-2031
Table 43: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Molecular Diagnostics, 2017-2031
Table 44: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 45: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global In Vitro Diagnostics Market Size, by Product & Service, 2022
Figure 02: In Vitro Diagnostics Market share (%), by Product & Service, 2022
Figure 03: In Vitro Diagnostics Market Size, by Technology, 2022
Figure 04: In Vitro Diagnostics Market share (%), by Technology, 2022
Figure 05: In Vitro Diagnostics Market Size, by Application, 2022
Figure 06: In Vitro Diagnostics Market share (%), by Application, 2022
Figure 07: In Vitro Diagnostics Market Size, by End-User, 2022
Figure 08: In Vitro Diagnostics Market share (%), by End-User, 2022
Figure 09: Global In Vitro Diagnostics Market, By Region (2022 and 2031)
Figure 10: Global In Vitro Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
Figure 11: Global In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 12: Global In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022
Figure 13: Global In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2031
Figure 14: Global In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 15: Global In Vitro Diagnostics Market Value (US$ Mn), by Reagents & Kits, 2017-2031
Figure 16: Global In Vitro Diagnostics Market Value Share Analysis, by Reagents & Kits, 2022 and 2031
Figure 17: Global In Vitro Diagnostics Market Value (US$ Mn), by Instruments, 2017-2031
Figure 18: Global In Vitro Diagnostics Market Value Share Analysis, Instruments, 2022 and 2031
Figure 19: Global In Vitro Diagnostics Market Value (US$ Mn), by Software & Services, 2017-2031
Figure 20: Global In Vitro Diagnostics Market Value Share Analysis, by Software & Services, 2022 and 2031
Figure 21: Global In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 22: Global In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022
Figure 23: Global In Vitro Diagnostics Market Value Share Analysis, by Technology, 2031
Figure 24: Global In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 25: Global In Vitro Diagnostics Market Value (US$ Mn), by Immunoassay, 2017-2031
Figure 26: Global In Vitro Diagnostics Market Value Share Analysis, by Immunoassay, 2022 and 2031
Figure 27: Global In Vitro Diagnostics Market Value (US$ Mn), by Clinical Chemistry, 2017-2031
Figure 28: Global In Vitro Diagnostics Market Value Share Analysis, Clinical Chemistry, 2022 and 2031
Figure 29: Global In Vitro Diagnostics Market Value (US$ Mn), by Molecular Diagnostics, 2017-2031
Figure 30: Global In Vitro Diagnostics Market Value Share Analysis, by Molecular Diagnostics, 2022 and 2031
Figure 31: Global In Vitro Diagnostics Market Value (US$ Mn), by Blood Glucose Monitoring, 2017-2031
Figure 32: Global In Vitro Diagnostics Market Value Share Analysis, Blood Glucose Monitoring, 2022 and 2031
Figure 33: Global In Vitro Diagnostics Market Value (US$ Mn), by Hematology, 2017-2031
Figure 34: Global In Vitro Diagnostics Market Value Share Analysis, by Molecular Diagnostics, 2022 and 2031
Figure 35: Global In Vitro Diagnostics Market Value (US$ Mn), by Others, 2017-2031
Figure 36: Global In Vitro Diagnostics Market Value Share Analysis, Blood Glucose Monitoring, 2022 and 2031
Figure 37: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 38: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2022
Figure 39: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2031
Figure 40: Global In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 41: Global In Vitro Diagnostics Market Value (US$ Mn), by Oncology, 2017-2031
Figure 42: Global In Vitro Diagnostics Market Value Share Analysis, by Oncology, 2022 and 2031
Figure 43: Global In Vitro Diagnostics Market Value (US$ Mn), by Infectious Diseases, 2017-2031
Figure 44: Global In Vitro Diagnostics Market Value Share Analysis, Infectious Diseases, 2022 and 2031
Figure 45: Global In Vitro Diagnostics Market Value (US$ Mn), by Metabolic Diseases, 2017-2031
Figure 46: Global In Vitro Diagnostics Market Value Share Analysis, by Metabolic Diseases, 2022 and 2031
Figure 47: Global In Vitro Diagnostics Market Value (US$ Mn), by Cardiology, 2017-2031
Figure 48: Global In Vitro Diagnostics Market Value Share Analysis, Cardiology, 2022 and 2031
Figure 49: Global In Vitro Diagnostics Market Value (US$ Mn), by Nephrology, 2017-2031
Figure 50: Global In Vitro Diagnostics Market Value Share Analysis, by Nephrology, 2022 and 2031
Figure 51 Global In Vitro Diagnostics Market Value (US$ Mn), by Drug Testing/Pharmacogenomics, 2017-2031
Figure 52: Global In Vitro Diagnostics Market Value Share Analysis, Drug Testing/pharmacogenomics, 2022 and 2031
Figure 53: Global In Vitro Diagnostics Market Value (US$ Mn), by Autoimmune Diseases, 2017-2031
Figure 54: Global In Vitro Diagnostics Market Value Share Analysis, by Autoimmune Diseases, 2022 and 2031
Figure 55: Global In Vitro Diagnostics Market Value (US$ Mn), by Others, 2017-2031
Figure 56: Global In Vitro Diagnostics Market Value Share Analysis, Others, 2022 and 2031
Figure 57: Global In Vitro Diagnostics Market Value Share Analysis, by End-User, 2022 and 2031
Figure 58: Global In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022
Figure 59: Global In Vitro Diagnostics Market Value Share Analysis, by Application, 2031
Figure 60: Global In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 61: Global In Vitro Diagnostics Market Value (US$ Mn), by Diagnostic Centers, 2017-2031
Figure 62: Global In Vitro Diagnostics Market Value Share Analysis, by Diagnostic Centers, 2022 and 2031
Figure 63: Global In Vitro Diagnostics Market Value (US$ Mn), by Hospital-based Laboratories, 2017-2031
Figure 64: Global In Vitro Diagnostics Market Value Share Analysis, Hospital-based Laboratories, 2022 and 2031
Figure 65: Global In Vitro Diagnostics Market Value (US$ Mn), by Academic & Research Institutes, 2017-2031
Figure 66: Global In Vitro Diagnostics Market Value Share Analysis, by Academic & Research Institutes, 2022 and 2031
Figure 67: Global In Vitro Diagnostics Market Value (US$ Mn), by Home care, 2017-2031
Figure 68: Global In Vitro Diagnostics Market Value Share Analysis, Home care, 2022 and 2031
Figure 69: Global In Vitro Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
Figure 70: Global In Vitro Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
Figure 71: North America In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 72: North America In Vitro Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
Figure 73: North America In Vitro Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
Figure 74: North America In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 75: North America In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 76: North America In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 77: North America In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 78: North America In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 79: North America In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 80: North America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 81: North America In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 82: Europe In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 83: Europe In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 84: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 85: Europe In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 86: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 87: Europe In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 88: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 89: Europe In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 90: Europe In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 91: Europe In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 92: Europe In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 93: Asia Pacific In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 94: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 95: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 96: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 97: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 98: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 99: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 100: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 101: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 102: Asia Pacific In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 103: Asia Pacific In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 104: Latin America In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 105: Latin America In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 106: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 107: Latin America In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 108: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 109: Latin America In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 110: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 111: Latin America In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 112: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 113: Latin America In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 114: Latin America In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
Figure 115: Middle East & Africa In Vitro Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 116: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 117: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 118: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Product & Service, 2022 and 2031
Figure 119: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Product & Service, 2023-2031
Figure 120: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Technology, 2022 and 2031
Figure 121: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Technology, 2023-2031
Figure 122: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 123: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 124: Middle East & Africa In Vitro Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 125: Middle East & Africa In Vitro Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security